Gujarat Terce Laboratories Ltd
Fundamental Score
Gujarat Terce Laboratories Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of GUJTERC across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Excellent ROCE Performance (41.41%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Conservative Debt Levels (D/E: 0.08)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (14.52x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
5 factors identified
Below-Average Return on Equity (-14.57%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Margin Pressure Concerns (0.72%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Gujarat Terce Laboratories Ltd
About GUJTERC
Business Overview
Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, Codimol, Cefter, and Terflora brands. Gujarat Terce Laboratories Limited was incorporated in 1985 and is based in Ahmedabad, India.
Company Details
Key Leadership
GUJTERC Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Gujarat Terce Laboratories Ltd (GUJTERC)?
As of 09 Feb 2026, 12:13 pm IST, Gujarat Terce Laboratories Ltd (GUJTERC) is currently trading at ₹42.38. The stock has a market capitalization of ₹34.63 (Cr).
Is GUJTERC share price Overvalued or Undervalued?
GUJTERC is currently trading at a P/E ratio of 0.00x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the Gujarat Terce Laboratories Ltd share price?
Key factors influencing GUJTERC's price include its quarterly earnings growth (Sales Growth: -2.78%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Gujarat Terce Laboratories Ltd a good stock for long-term investment?
Gujarat Terce Laboratories Ltd shows a 5-year Profit Growth of N/A% and an ROE of -14.57%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.08 before investing.
How does Gujarat Terce Laboratories Ltd compare with its industry peers?
Gujarat Terce Laboratories Ltd competes with major peers in the Pharmaceuticals. Investors should compare GUJTERC's P/E of 0.00x and ROE of -14.57% against the industry averages to determine its competitive standing.
What is the P/E ratio of GUJTERC and what does it mean?
GUJTERC has a P/E ratio of N/Ax compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is GUJTERC performing according to Bull Run's analysis?
GUJTERC has a Bull Run fundamental score of 8.5/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does GUJTERC belong to?
GUJTERC operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Gujarat Terce Laboratories Ltd.
What is Return on Equity (ROE) and why is it important for GUJTERC?
GUJTERC has an ROE of -14.57%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Gujarat Terce Laboratories Ltd generates profits from shareholders' equity.
How is GUJTERC's debt-to-equity ratio and what does it indicate?
GUJTERC has a debt-to-equity ratio of 0.08, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is GUJTERC's dividend yield and is it a good dividend stock?
GUJTERC offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has GUJTERC grown over the past 5 years?
GUJTERC has achieved 5-year growth rates of: Sales Growth 5.98%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in GUJTERC and why does it matter?
Promoters hold 37.03% of GUJTERC shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is GUJTERC's market capitalization category?
GUJTERC has a market capitalization of ₹35 crores, placing it in the Small-cap category.
How volatile is GUJTERC stock?
GUJTERC has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for GUJTERC?
GUJTERC has a 52-week high of ₹N/A and low of ₹N/A.
What is GUJTERC's operating profit margin trend?
GUJTERC has a 5-year average Operating Profit Margin (OPM) of 0.72%, indicating the company's operational efficiency.
How is GUJTERC's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -2.78% and YoY Profit Growth of -5.41%.
What is the institutional holding pattern in GUJTERC?
GUJTERC has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.